Prenatal screening by cell-free DNA (cfDNA) involves sequencing fetal cfDNA in maternal blood, but it is mostly limited to low-resolution...

Single-nucleotide variants (SNVs) are the leading cause of inherited single-gene disorders (SGDs). Identifying SNVs in a non-invasive prenatal...

Birth defects are innate developmental errors, encompassing structural or functional irregularities that impact physical, mental, and social wellbeing...

Single-nucleotide variants (SNVs) are of great significance in prenatal diagnosis as they are the leading cause of inherited single-gene...

Identifai-Genetics, developer of unique AI-based solutions for non-invasive fetal DNA sequencing, announced today that it has launched its first...

Israeli startup Identifai Genetics says it can determine whether a baby will be born with any kind of genetic disorder...

Identifai offers unique, innovative solutions for the non-invasive detection of fetal genetic disorders, at an early stage of the...

We are delighted to announce that Identifai-Genetics won the approval the Israel Innovation Authority (IIA) for a NIS 9M...

The technology of noninvasive prenatal testing (NIPT) enables risk-free detection of genetic conditions in the fetus, by analysis of cell...

In the last decade, noninvasive prenatal diagnosis (NIPD) has emerged as an effective procedure for early detection of inherited diseases...

Noninvasive prenatal diagnosis (NIPD) is a risk-free alternative to invasive methods for prenatal diagnosis,e.g. amniocentesis. NIPD is based on...